Please login to the form below
23
Revenue 2017Copaxone
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Copaxone was produced by Teva and Sanofi.
Teva’s weak pipeline hit by Tourette’s drug trial failure
of a weak market for its generic drugs and declining sales of former cash cow Copaxone (glatiramer acetate) for multiple sclerosis.
Teva names new CFO and bulks up its opioid liability fund
Teva’s third-quarter results were hit once again by weak generic sales and the continuing erosion of multiple sclerosis therapy Copaxone (glatiramer acetate) which has lost patent protection and is
Sandoz finally wins FDA approval for Neulasta biosimilar
This includes all biosimilars, biopharmaceutical contract manufacturing and Glatopa sales – Sandoz’ generic of Teva’s multiple sclerosis drug Copaxone.
Biogen trumpets safety data for Tecfidera follow-up
The patients – who were either newly-diagnosed cases or had previously been switched from injectable beta interferon drugs or Teva’s Copaxone (glatiramer acetate) – also saw the mean number of
Teva’s migraine injection approved in Europe
Its income is expected to slip 8% to 10% in 2019, thanks to the decline of its biggest seller, MS drug Copaxone.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn
- Landscape review reveals £1.1bn of UK funding for rare diseases
- Cancer Research UK partners with French cancer institute
- New diagnosis pathway has been launched to mark European Myeloma Day
- Impacting Lives with Rare Disease Education
- Sandoz biosimilar receives EC approval to treat MS
No results were found
PMHub
Graphite Digital
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
